2m 2m 2m 2m 2m 2m 2m
Vanda Pharma (VNDA)
NASDAQ
$5.97+$0.02 (+0.40%)
Price as of Jun 23, 2026 7:24 PM EDT- $360.8MMarket Cap
- 32.22%1-Year Change
- BiotechnologyIndustry
Vanda Pharma (VNDA)
$5.97+$0.02 (+0.40%)
VNDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.95 | ||
Change | -$0.05 (-0.83%) | ||
Open | $5.97 | ||
High | $6.11 | ||
Low | $5.93 | ||
Previous Close | $6.00 | ||
Volume | 584,863 | ||
30-Day Average Volume | 951,837 | ||
1-Week Change | 3.84% | ||
1-Month Change | -3.88% | ||
1-Year Change | 32.22% | ||
3-Year Change | -8.74% | ||
5-Year Change | -68.52% | ||
Fundamentals | |||
Shares Outstanding | 60.1M | ||
Total Assets | $433.5M | ||
Market Cap | $360.8M | ||
Enterprise Value | $306.8M | ||
Period: QTR TTM FY | |||
Revenue | $51.7M | ||
Net Income | -$48.6M | ||
Free Cash Flow | -$50.4M | ||
EBIT | -$48.4M | ||
EBITDA | -$46.4M | ||
Net Working Capital | $157.6M | ||
EPS | -$0.82 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | -0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue